IL6 and rheumatoid arthritis: A study on a monoclonal antibody (tocilizumab) to transmembrane and sIL-6Rα showed that tocilizumab was effective in patients with rheumatoid arthritis although tocilizumab increased serum levels of IL-6 and sIL-6Rα.